Cited by 305Medical Imaging Techniques and ApplicationsRenal cell carcinoma treatmentRadiomics and Machine Learning in Medical Imaging

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Clinical Use of Fluorodeoxyglucose F 18 Positron Emission Tomography for Detection of Renal Cell Carcinoma

KANG, DAVID E., WHITE, RICHARD L., ZUGER, JAMES H., SASSER, HOWELL C., TEIGLAND, CHRIS M.·2004·Journal of Urology

DOI 10.1097/01.ju.0000120241.50061.e4

Open this paper in CoChat — free account

Abstract

Purpose We evaluate the role of fluorodeoxyglucose F 18 positron emission tomography (PET) in patients with renal cell carcinoma (RCC) by retrospective review. To our knowledge this series is the largest reviewing the use of PET in patients with RCC. Materials and methods A total of 66 patients who underwent 90 PET scans for suspected or known RCC were identified. Dictated reports of PET, chest computerized tomography (CT), abdominal/pelvic CT and bone scan were examined with confirmation of results by histopathology or followup of at least 1 year. The accuracies of PET and conventional imaging modalities were compared. Results PET exhibited a sensitivity of 60% and specificity of 100% for primary RCC tumors (abdominal CT demonstrated 91.7% sensitivity and 100% specificity). For retroperitoneal lymph node metastases and/or renal bed recurrence, PET was 75.0% sensitive and 100.0% specific (92.6% sensitivity and 98.1% specificity for abdominal CT). PET had a sensitivity of 75.0% and a specificity of 97.1% for metastases to the lung parenchyma compared to 91.1% and 73.1%, respectively, for chest CT. PET had a sensitivity of 77.3% and specificity of 100.0% for bone metastases, compared to 93.8% and 87.2% for combined CT and bone scan. In 39 scans (32 patients) PET failed to detect RCC lesions identified by conventional imaging. Conclusions The role of fluorodeoxyglucose F 18 PET in the detection of RCC is limited by low sensitivity. With superior specificity PET may have a comple…

Integrity signals

Registry

Crossref · 10.1097/01.ju.0000120241.50061.e4

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Data analysis
Sivia, D. S. (1996) · Cited by 2,669
Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging
Schiepers, C. W., PENNINCKX, F. M., Vadder, N. D., Merckx, E., Mortelmans, L., Bormans, G. M., Marchal, G., Filez, L., & Aerts, R. (1995) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(95)97046-0 · Cited by 233
Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose
Avril, N. E., Dose, J., Jänicke, F., Ziegler, S. I., Römer, W., Weber, W., Herz, M., NATHRATH, W. B. J., Graeff, H., & Schwaiger, M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.17.1204 · Cited by 213
CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMA
Ramdave, S., Thomas, G., Berlangieri, S. U., Bolton, D. M., Davis, I. D., DANGUY, H.-T., MacGregor, D. P., & Scott, A. M. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65845-4 · Cited by 206
Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy
Bailet, J. W., Abemayor, E., Jabour, B. A., Hawkins, R. A., Ho, C., & Ward, P. H. (1992) · The Laryngoscope · doi:10.1288/00005537-199203000-00010 · Cited by 204
Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose
Scott, W. J., Schwabe, J. L., Gupta, N. C., Dewan, N. A., Reeb, S. D., & Sugimoto, J. T. (1994) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)90730-7 · Cited by 172
The usefulness of F-18 deoxyglucose wholebody positron emission tomography (PET) for re-staging of renal cell cancer
Safaei, A., Figlin, R. A., Hoh, C. K., Silverman, D. H. S., Seltzer, M., Phelps, M. E., & Czernin, J. (2002) · Clinical Nephrology · doi:10.5414/cnp57056 · Cited by 131
Significance of 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT‐1) expression in the cancer
Miyakita, H., TOKUNAGA, M., Onda, H., USUI, Y., Kinoshita, H., Kawamura, N., & Yasuda, S. (2002) · International Journal of Urology · doi:10.1046/j.1442-2042.2002.00416.x · Cited by 115
Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - a preliminary report
Wu, H., Yen, R., Shen, Y., Kao, C., Lin, C., & Lee, C. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-002-0370-1 · Cited by 110
[Positron emission tomography in diagnosis of renal cell carcinoma].
Bachor, R., Kotzerke, J., Hw, G., Brandle, E., Sn, R., & Hautmann, R. E. (1996) · PubMed · Cited by 86

Show all 14 references

Items 101–200 of 304

Positron emission tomography in uro-oncology
Hain, S. F. (2005) · Cancer Imaging · doi:10.1102/1470-7330.2005.0001 · Cited by 21
Can Initial 18F-FDG PET-CT Imaging Give Information on Metastasis in Patients with Primary Renal Cell Carcinoma?
Lee, H., Hwang, K. H., Kim, S. G., Koh, G., & Kim, J. H. (2013) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-013-0245-1 · Cited by 20
Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET/CT: a pictorial essay
Makis, W., Ciarallo, A., Rakheja, R., Probst, S., Hickeson, M. P., Rush, C., Novales-Diaz, J. A., Derbekyan, V. A., Stern, J., & Lisbona, R. (2012) · Clinical Imaging · doi:10.1016/j.clinimag.2012.01.010 · Cited by 18
Diagnostic modalities
Elstob, A., Gonsalves, M., & Patel, U. (2016) · International Journal of Surgery · doi:10.1016/j.ijsu.2016.06.005 · Cited by 18
A Rare Presentation of Metastatic Renal Clear Cell Carcinoma to the Tongue Seen on FDG PET
Basely, M., Bonnel, S., Maszelin, P., Verdalle, P., Bussy, E., & de Jauréguiberry, J.-P. (2009) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3181b06ad7 · Cited by 18
Primary synovial sarcoma of the kidney: use of PET/CT in diagnosis and follow-up
Erturhan, S. M., Şeçkiner, İ., Zincirkeser, S., Erbağcı, A., Çelik, M., Yağcı, F., & Karakök, M. (2008) · Annals of Nuclear Medicine · doi:10.1007/s12149-007-0093-0 · Cited by 17
Metastatic clear cell renal cell carcinoma demonstrating intense uptake on 68Ga-DOTATATE positron emission tomography: Three case reports and a review of the literature
Nadebaum, D. P., Lee, S., Nikfarjam, M., & Scott, A. M. (2018) · World Journal of Nuclear Medicine · doi:10.4103/wjnm.wjnm_38_17 · Cited by 17
Analysis of the Roles of Glucose Transporter 1 and Hexokinase 2 in the Metabolism of Glucose by Extrahepatic Bile Duct Cancer Cells
Yoon, S. O., Jeon, T. J., Park, J. S., Ryu, Y. H., Lee, J., Yoo, J. S., Kim, J. K., Yoon, D. S., & Oh, E. J. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000640 · Cited by 17
Standardized Uptake Values Highly Correlate with Tumor Size and Fuhrman Grade in Patients with Clear Cell Renal Cell Carcinoma
Polat, E. C., Ötünçtemur, A., Özbek, E., Beşiroğlu, H., Dursun, M., Özer, K., & Horsanalı, M. O. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.18.7821 · Cited by 17
Widespread metastases from sarcomatoid renal cell carcinoma detected by 18F-FDG positron emission tomography/computed tomography
Hyodo, T., Sugawara, Y., Tsuda, T., Yanagihara, Y., Aoki, K., Tanji, N., Hirata, M., Murakami, M., Miyagawa, M., Yokoyama, M., et al. (2009) · Japanese Journal of Radiology · doi:10.1007/s11604-008-0305-0 · Cited by 17
Oligometastatic Renal Cell Carcinoma With Sarcomatoid Differentiation Demonstrating Variable Imaging Phenotypes on 68Ga-PSMA and 18F-FDG PET/CT: A Case Report and Review of the Literature
Nadebaum, D. P., Hofman, M. S., Mitchell, C., Siva, S., & Hicks, R. J. (2017) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2017.08.009 · Cited by 17
The regulation of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase by autophagy in low-glycolytic hepatocellular carcinoma cells
Jeon, J. Y., Lee, H., Park, J., Lee, M., Park, S. W., Kim, J. S., Lee, M., Cho, B. C., Kim, K., Choi, A. M. K., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.103 · Cited by 16
Assessment of Combination of Contrast-Enhanced Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Evaluation of Ovarian Masses
Tsuboyama, T., Tatsumi, M., Onishi, H., Nakamoto, A., Kim, T., Hori, M., Sakane, M., Hori, Y., Morii, E., Hatazawa, J., et al. (2014) · Investigative Radiology · doi:10.1097/rli.0000000000000050 · Cited by 16
FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma
Nakaigawa, N., Kondo, K., Kaneta, T., Tateishi, U., Minamimoto, R., Namura, K., Ueno, D., Kobayashi, K., Kishida, T., Ikeda, I., et al. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3542-7 · Cited by 16
Role of positron emission tomography/computed tomography in the evaluation of renal cell carcinoma
Jena, R., Narain, T. A., Singh, U. P., & Srivastava, A. (2021) · Indian Journal of Urology · doi:10.4103/iju.iju_268_20 · Cited by 15
FDG Uptake in Inferior Vena Cava Tumor Thrombus From Renal Cell Carcinoma on Positron Emission Tomography
Sizemore, A. W., JACOBS, M. P., Mantil, J., & Hahm, G. K. (2007) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000257277.80226.aa · Cited by 15
La tomografía por emisión de positrones (pet) y pet-tac en riñón, vías urinarias y próstata: actualización
Bolton, R. C. D., Rasilla, J. M., Castejón, M. J. P., & Delgado, J. L. C. (2009) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(09)73997-x · Cited by 15
Molecular Imaging of Renal Cell Carcinoma in Precision Medicine
Wu, Q., Huang, G., Wei, W., & Liu, J. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00034 · Cited by 14
Collecting duct carcinoma of the kidney: Imaging observations of a rare tumor
Hu, Y., Lu, G.-M., Li, K., Zhang, L. J., & ZHU, H. (2013) · Oncology Letters · doi:10.3892/ol.2013.1739 · Cited by 14
Immunotherapy response evaluation with 18F-FDG-PET in patients with advanced stage renal cell carcinoma
Gilles, R., de Geus‐Oei, L., Mulders, P., & Oyen, W. J. G. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0723-y · Cited by 14
Non-FDG PET/CT
Lopci, E., & Fanti, S. (2020) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-42618-7_20 · Cited by 14
Renal Cell Carcinoma Ablation: Preprocedural, Intraprocedural, and Postprocedural Imaging
Joe, W. B., Zarzour, J. G., & Gunn, A. J. (2019) · Radiology Imaging Cancer · doi:10.1148/rycan.2019190002 · Cited by 13
Evidence‐based clinical practice guidelines for renal cell carcinoma (Summary – JUA 2007 Edition)
Fujioka, T., & Obara, W. (2009) · International Journal of Urology · doi:10.1111/j.1442-2042.2008.02242.x · Cited by 13
PET in abdominal pathology: advantages and limitations
Salmon, A. S., Salgado, J. B., & Ruibal, Á. (2006) · Abdominal Imaging · doi:10.1007/s00261-005-0384-7 · Cited by 13
Imaging in genitourinary cancer from the urologists�� perspective
Tsakiris, P. (2007) · Cancer Imaging · doi:10.1102/1470-7330.2007.0009 · Cited by 13
Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study
Minamimoto, R., Nakaigawa, N., Nagashima, Y., Toyohara, J., Ueno, D., Namura, K., Nakajima, K., Yao, M., & Kubota, K. (2016) · Abdominal Radiology · doi:10.1007/s00261-015-0601-y · Cited by 12
68Ga-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor
Soydal, Ç., Nak, D., Araz, M., Demirkazık, A., & Küçük, Ö. (2019) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002718 · Cited by 13
Sarcomatoid renal cell carcinoma: Rapid dissemination detected on FDG PET‐CT
Thambugala, G., Mohamed, A., Neill, G. O., & FULHAM, M. J. (2006) · Australasian Radiology · doi:10.1111/j.1440-1673.2006.01664.x · Cited by 12
Metastatic Renal Cell Carcinoma
Lin, S., Bierhals, A. J., & Lewis, J. S. (2007) · Radiographics · doi:10.1148/rg.276075013 · Cited by 12
Does PET imaging have a role in renal cancers after all?
Powles, T. B., & Ell, P. J. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70080-3 · Cited by 12
Intratestikuläre Metastasierung eines Nierenzellkarzinoms
Schmorl, P., Ostertag, H., & Conrad, S. (2008) · Der Urologe · doi:10.1007/s00120-008-1738-x · Cited by 11
Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM)
Vitale, M. G., Sergio Bracarda, A., Cosmai, L., Crocetti, E., Lorenzo, G. D., Lapini, A., Mandressi, A., Martorana, G. E., Masini, C., Montironi, R., et al. (2019) · Tumori Journal · doi:10.1177/0300891619853392 · Cited by 11
Secondary Tumors of the Kidney: A Comprehensive Clinicopathologic Analysis
Saeed, F., & Osunkoya, A. O. (2022) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000338 · Cited by 11
PET/CT Limitations and Pitfalls in Urogenital Cancers
Vasireddi, A. K., & Nguyen, N. C. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2021.06.013 · Cited by 11
Osteoblastic bone metastases in breast cancer: is not seeing believing?
Fogelman, I. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1869-x · Cited by 11
Computed Tomography in Metastatic Renal Cell Carcinoma
Griffin, N., Grant, L. A., Bharwani, N., & Sohaib, S. A. (2009) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2009.03.007 · Cited by 11
Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma
Ozawa, N., Okamura, T., Koyama, K., Hamazawa, Y., Senzaki, H., Tanabe, S., Ikemoto, S., & Inoue, Y. (2007) · Annals of Nuclear Medicine · doi:10.1007/s12149-007-0011-5 · Cited by 11
Positronenemissionstomographie (PET) zur Diagnostik und zum Therapiemonitoring bei urologischen Tumoren
Machtens, S. A., Boerner, A. R., Hofmann, M., Knapp, W. H., & Udo Jonas, A. (2004) · Der Urologe · doi:10.1007/s00120-004-0714-3 · Cited by 11
Molecular Imaging in Oncology
Lopci, E., & Fanti, S. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-10853-2_13 · Cited by 10
Elucidating the Relationship Between Diabetes Mellitus and Parkinson’s Disease Using 18F-FP-(+)-DTBZ, a Positron-Emission Tomography Probe for Vesicular Monoamine Transporter 2
Kong, Y., Zhou, H., Feng, H., Zhuang, J., Wen, T., Zhang, C., Sun, B., Wang, J., & Guan, Y. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00682 · Cited by 10
Role of contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of renal tumors
Gündoğan, C., Çermik, T. F., Erkan, E., Yardımcı, A. H., Behzatoğlu, K., Tatar, G., Okçu, O., & Toktaş, M. G. (2018) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000915 · Cited by 10
Is The Value of FDG PET/CT in Evaluating Renal Metastasis Underestimated? A Case Report and Review of The Literature
Aras, M., Dede, F., Önes, T., İnanır, S., Erdıl, T. Y., & Turoğlu, H. T. (2013) · Molecular Imaging and Radionuclide Therapy · doi:10.4274/mirt.130 · Cited by 10
Recent developments in kidney cancer
Leveridge, M., & Jewett, M. A. S. (2011) · Canadian Urological Association Journal · doi:10.5489/cuaj.10148 · Cited by 9
Molecular Imaging of Renal Cell Carcinoma
Perini, R. F., Pryma, D. A., & Divgi, C. R. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.015 · Cited by 9
Metastatic Renal Cell Carcinoma to the Spine and the Extremities
Louie, P. K., Sayari, A. J., Frank, R. M., An, H. S., & Colman, M. W. (2019) · JBJS Reviews · doi:10.2106/jbjs.rvw.19.00002 · Cited by 9
Wertigkeit der Bildgebung für die Lymphknotenmetastasierung beim Nierenzell-, Blasen-, Prostata- und Peniskarzinom sowie dem Hodentumor
Stattaus, J., Bockisch, A., Forsting, M., & Müller, S. P. (2005) · Der Urologe · doi:10.1007/s00120-005-0830-8 · Cited by 9
PET/CT imaging of clear cell renal cell carcinoma with 124I labeled chimeric antibody
Bahnson, E. E., Murrey, D. A., Mojzisik, C. M., Hall, N. C., Martinez‐Suarez, H. J., Knopp, M. V., Martin, E. W., Povoski, S. P., & Bahnson, R. R. (2009) · Therapeutic Advances in Urology · doi:10.1177/1756287209105264 · Cited by 8
Imaging techniques as predictive and prognostic biomarkers in renal cell carcinoma
Nathan, P., & Vinayan, A. (2012) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834012463624 · Cited by 8
Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of MDCT
Ganeshan, D., Morani, A., Ladha, H. S., Bathala, T. K., Kang, H. C., Gupta, S., Lalwani, N., & Kundra, V. (2013) · Abdominal Imaging · doi:10.1007/s00261-013-0037-1 · Cited by 8
Diagnosis of bone metastases in urological malignancies—an update
Ong, S., Bagguley, D., Rajarubendra, N., & Lawrentschuk, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00062-1 · Cited by 8
Role of 18F-FDG PET/CT for detection of recurrence and metastases in renal cell carcinoma—are we underusing PET/CT?
Pereira, M., Punatar, C. B., Singh, N., & Sagade, S. N. (2022) · Diagnostic and Interventional Radiology · doi:10.5152/dir.2022.21096 · Cited by 7
Integrating Surgery in the Multidisciplinary Care of Advanced Renal Cell Carcinoma
Ray, S., Dason, S., & Singer, E. A. (2023) · Urologic Clinics of North America · doi:10.1016/j.ucl.2023.01.013 · Cited by 7
Contrast-enhanced CT in 100 clear cell renal cell cancers — an analysis of enhancement, tumour size, and survival
Veeratterapillay, R., Ijabla, R., Conaway, D., Haslam, P. J., Soomro, N., & Heer, R. (2015) · Clinical Radiology · doi:10.1016/j.crad.2015.07.006 · Cited by 7
Isolated rib metastases from renal cell carcinoma
Assouad, J., Masmoudi, H., Berna, P., Steltzlen, C., Radu, D. M., Riquet, M., & Grunenwald, D. H. (2009) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2009.210997 · Cited by 7
The detection of renal cell carcinoma with adrenal and para-aortic lymph node metastases by FDG-PET
Ide, M., Suzuki, Y., Kameyama, G., Takahashi, W., Koide, S., Hinohara, S., & Kawada, S. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1870-4 · Cited by 7
Differentiating renal pelvic cancer from renal cell carcinoma with 18-fluorodeoxyglucose positron emission tomography-computed tomography
Dursun, M., Özbek, E., Ötünçtemur, A., & Beşiroğlu, H. (2019) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_217_16 · Cited by 6
Von Hippel-Lindau disease type 2 in a Chinese family with a VHL p.W88X truncation
Zhang, M., Wang, J., Jiang, J., Zhan, X., Ling, Y., Lu, Z., Guo, J., & Gao, X. (2014) · Endocrine · doi:10.1007/s12020-014-0368-x · Cited by 6
Imaging Features of Renal Cell Carcinoma Differential Diagnosis, Staging, and Posttreatment Evaluation
Jinzaki, M., Akita, H., & Oya, M. (2017) · Springer eBooks · doi:10.1007/978-4-431-55531-5_5 · Cited by 6
Recent advances in imaging techniques of renal masses
Aggarwal, A., Das, C. J., & Sharma, S. (2022) · World Journal of Radiology · doi:10.4329/wjr.v14.i6.137 · Cited by 6
Positron emission tomography: clinical applications in oncology. Part 2
Kumar, R., & Chauhan, A. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.4.625 · Cited by 6
68Ga-dotatoc vs. 18F-FDG vs. radiolabelled PSMA PET/CT in renal cancer patients
Evangelista, L., Zattoni, F., & Alongi, P. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.06.28 · Cited by 6
Stellenwert der Positronenemissionstomographie bei urologischen Tumoren
Müller, J., Schrader, M., Schrader, A. J., Höpfner, M., & Zengerling, F. (2012) · Der Urologe · doi:10.1007/s00120-012-2834-5 · Cited by 5
PET/CT for the diagnostic assessment of patients with renal cancer
Fiasconaro, E., Caobelli, F., Quartuccio, N., Messina, M., Spada, M., Albano, D., & Alongi, P. (2018) · Clinical and Translational Imaging · doi:10.1007/s40336-018-0278-7 · Cited by 5
Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging
Lee, S. H., Park, J. S., Kim, H. J., Kim, D., Lee, S. H., Ham, W. S., Han, W. K., Choi, Y. D., & Yun, M. (2021) · Cancers · doi:10.3390/cancers13102381 · Cited by 5
Three Cases of Renal Cell Carcinoma Metastasizing to the Head and Neck
Ito, R., Nishiike, S., Tomiyama, Y., Yoshii, T., Yamamoto, Y., & Inohara, H. (2011) · Nippon Jibiinkoka Gakkai Kaiho · doi:10.3950/jibiinkoka.114.864 · Cited by 5
Synthèse de veille 2006 Recommandations pour la pratique clinique : utilisation de la TEP-FDG dans les cancers du rein, de la prostate, du testicule et de la vessie
Bourguet, P., Planchamp, F., Montravers, F., & Vincendeau, S. (2007) · The French Journal of Urology · doi:10.1016/s1166-7087(07)92256-3 · Cited by 5
Dual modality imaging of positron emission tomography-computed tomography (PET-CT) in evaluation of postoperative renal cancer patients
Youssef, M. A., Elshafey, M. H., Moghazy, K., & Elrashedy, A. A. (2018) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1016/j.ejrnm.2018.06.014 · Cited by 4
Diagnostic Applications of Nuclear Medicine: Kidney and Bladder Cancer
Bouchelouche, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-26236-9_20 · Cited by 4
Breast Carcinoma Metastatic to Renal Oncocytoma Detected on F-18-FDG PET/CT
Fox, J. J., Rohan, S. M., & Pandit-Taskar, N. D. (2009) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31819e51ce · Cited by 4
Trends in PET Scan Usage for Imaging of Patients Diagnosed With Nonmetastatic Urologic Cancer
Adejoro, O. O., Alishahi, A., Soubra, A., & Konety, B. R. (2015) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2015.09.002 · Cited by 4
FDG-PET Imaging in Oncology
Schiepers, C. W., & Hoh, C. K. (2006) · Medical radiology · doi:10.1007/3-540-30005-8_11 · Cited by 4
Pearls and Pitfalls in Interpretation of Abdominal and Pelvic
Blake, M. A., Singh, A. N., Slattery, J. M. A., Kalra, M. K., Maher, M. M., Sahani, D. V., Fischman, A. J., & Müeller, P. R. (2006) · Cited by 4
Renal Cell Carcinoma
Barker, D. W., & Zagoria, R. J. (2005) · Medical radiology · doi:10.1007/3-540-30003-1_7 · Cited by 4
Practical issues in abdominal PET/CT
Blake, M. A., Slattery, J. M. A., Sahani, D. V., & Kalra, M. K. (2005) · Applied Radiology · doi:10.37549/ar1380 · Cited by 4
Renal Cell Carcinoma: Clinical Presentation, Staging, and Prognostic Factors
Vankayala, H. M., Shi, D., & Vaishampayan, U. N. (2011) · Springer eBooks · doi:10.1007/978-3-642-21858-3_5 · Cited by 3
Synchronous Oligometastatic Non-Small Cell Lung Cancer and Isolated Renal Cell Carcinoma: A Case Report and Literature Review
Nguyen, T. K., & Louie, A. V. (2015) · Cureus · doi:10.7759/cureus.366 · Cited by 3
Three Primary Carcinomas on 18F-FDG PET/CT
Wu, D., Hu, Y., Wei, Q., Tian, C., & 边艳珠 (2018) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002070 · Cited by 3
Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters
Arıkan, R., Özgüven, S., Telli, T. A., Işık, S., Demircan, N. C., Başoğlu, T., Yaşar, A., Çelebi, A., Filizoğlu, N., Ustun, H. S., et al. (2022) · Acta Radiologica · doi:10.1177/02841851221140504 · Cited by 3
Renal cell oncocytoma tumor evolutions: a case report
Alduraibi, A. K., Essa, N. B., & Bomanji, J. B. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1282508 · Cited by 3
Increased 18F-FDG Uptake on PET/CT is Associated With Poor Arterial and Portal Perfusion on Multiphase CT
Hwang, S. H., Lee, M., Lee, N., Park, S., Kim, C. K., Park, M., & Yun, M. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001105 · Cited by 3
Molecular Imaging of Renal Cell Carcinoma: A Comprehensive Review
Metwalli, A. R. (2012) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000117 · Cited by 3
A rare site of hyoid bone metastasis in patients with renal cell carcinoma on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography scan
Passah, A., Agarwal, K. K., Arunraj, S. T., Kumar, R., & Bal, C. (2016) · Indian Journal of Nuclear Medicine · doi:10.4103/0972-3919.190806 · Cited by 3
Late duodenal metastasis from renal cell carcinoma with newly developed malignant lymphoma: A case report
Saito, M., Senjo, H., Kanaya, M., Izumiyama, K., Mori, A., Tanaka, M., Morioka, M., Miyashita, K., & Ishida, Y. (2018) · Molecular and Clinical Oncology · doi:10.3892/mco.2018.1563 · Cited by 3
PET/CT in Abdominal and Pelvic Malignancies: Principles and Practices
Moore, M., & Blake, M. A. (2008) · Springer eBooks · doi:10.1007/978-88-470-0832-8_15 · Cited by 3
Biodistribution and Imaging
Olafsen, T., & Wu, A. M. (2009) · Wiley eBooks · doi:10.1002/9780470485408.ch20 · Cited by 3
Diagnostic Kidney Imaging
Boswell, W. D., Jadvar, H., & Palmer, S. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10027-2 · Cited by 2
[Case of renal cell carcinoma with intertrabecular vertebral metastases detected f-18 fluorodeoxyglucose positron emission tomography and MRI].
Yoneyama, S., Yumura, Y., Koizumi, M., Hanai, T., Ishida, H., Hattori, Y., Teranishi, J., Miyoshi, Y., Kondo, K., & Noguchi, K. (2014) · PubMed · Cited by 2
Utility of FDG-PET/CT in Patients with Advanced Renal Cell Carcinoma with Osseous Metastases: Comparison with CT and 99m Tc-MDP Bone Scan in a Prospective Clinical Trial
Dibble, E. H., Kravets, S., Cheng, S., Sakellis, C. G., Gray, K. P., Abbott, A., Bossé, D., Pomerantz, M. M., McGregor, B. A., Harshman, L. C., et al. (2019) · Kidney Cancer · doi:10.3233/kca-190075 · Cited by 2
Carcinoma of Unknown Original Identified as Renal Cell Carcinoma by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan: A Report of Two Cases
Kono, Y., Utsunomiya, K., Ohe, C., Takizawa, N., & Tanigawa, N. (2022) · Cureus · doi:10.7759/cureus.29827 · Cited by 2
A case of resectable pancreatic metastasis from renal cell carcinoma without FDG accumulation on PET
Suzuki, K., Watada, S., Mitsui, Y., Asakura, H., Sakamoto, M., & Tanimoto, N. (2010) · Suizo · doi:10.2958/suizo.25.67 · Cited by 2
Bellini Duct Carcinoma
Marx, K., Bauer, J. A., Guillou, L., Delaloye, A. B., & Prior, J. O. (2009) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3181abb768 · Cited by 2
Positron Emission Tomography in Urology
de Jong, I. J., Breeuwsma, A. J., & Pruim, J. (2007) · EAU-EBU Update Series · doi:10.1016/j.eeus.2007.01.002 · Cited by 2
Renal Mucinous Tubular and Spindle Cell Carcinoma and 18F-Fluorodeoxyglucose-PET/CT Findings
Öztürk, H. (2014) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2014.03.011 · Cited by 2
An iterative sinogram gap-filling method with object- and scanner-dedicated discrete cosine transform (DCT)-domain filters for high resolution PET scanners
Kim, K., Lee, K., Lee, H., Joo, S., & Kang, J. (2017) · Japanese Journal of Radiology · doi:10.1007/s11604-017-0697-9 · Cited by 2
Imaging in Renal Cell Carcinoma
Hayashi, D., Guermazi, A., & Holalkere, N.-S. (2014) · Medical radiology · doi:10.1007/978-3-642-54047-9_21 · Cited by 2
Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response
Thabet, A., Kalva, S. P., & Gervais, D. A. (2008) · Abdominal Imaging · doi:10.1007/s00261-008-9476-5 · Cited by 2
PET/CT Findings in Renal Cancer
Nikaki, A. V. (2018) · Springer eBooks · doi:10.1007/978-3-319-68873-2_76 · Cited by 2
Recent developments in kidney cancer
Leveridge, M., & Jewett, M. A. S. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.642 · Cited by 2
Renal Neoplasia
Delacroix, S. E., Wood, C. G., & Jonasch, E. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10040-5 · Cited by 2
[18F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma
Farulla, L. S. A., Travaini, L. L., Cuomo, M., Galetta, D., Mattana, F., Frassoni, S., Buonsanti, G., Muraglia, L., Zuccotti, G. A., Bagnardi, V., et al. (2023) · Tomography · doi:10.3390/tomography9010031 · Cited by 2

Authors: KANG, D. E., WHITE, R. L., ZUGER, J. H., SASSER, H. C., & TEIGLAND, C. M.
Affiliations: Carolinas Medical Center (US)
ORCID: WHITE, RICHARD L.
Venue: Journal of Urology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-05
Volume: 171
Issue: 5
Pages: 1806-1809
ISSN: 0022-5347 (ISSN-L)
1527-3792
DOI: 10.1097/01.ju.0000120241.50061.e4
OpenAlex: W2103792773
Cited by: 305
References: 14
Citations by year: 2026: 4 · 2025: 2 · 2024: 4 · 2023: 7 · 2022: 14 · 2021: 6 · 2020: 6 · 2019: 16 · 2018: 14 · 2017: 13 · 2016: 19 · 2015: 17 · 2014: 15 · 2013: 16 · 2012: 20
FWCI: 14.53
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Journal of Urology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
Keywords: renal cell carcinoma, tumor detection, diagnostic accuracy, sensitivity and specificity, retroperitoneal lymph node metastasis, lung metastasis, bone metastasis, abdominal CT, chest CT, bone scintigraphy
MeSH terms: Adult, Aged, Carcinoma, Renal Cell, Female, Humans, Kidney Neoplasms, Male, Middle Aged, Retrospective Studies, Tomography, Emission-Computed, Radiopharmaceuticals, Fluorodeoxyglucose F18

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Clinical Use of Fluorodeoxyglucose F 18 Positron Emission Tomography for Detection of Renal Cell Carcinoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks

Data sources